Lenz HJ - Search Results

1

Cytokeratin-20 and Survivin-Expressing Circulating Tumor Cells Predict Survival in Metastatic Colorectal Cancer Patients by a Combined Immunomagnetic qRT-PCR Approach.

Ning Y, Hanna DL, Zhang W, Mendez A, Yang D, El-Khoueiry R, Matsusaka S, Sunakawa Y, Stremitzer S, Parekh A, Okazaki S, Berger MD, Barzi A, Lenz HJ. Ning Y, et al. Among authors: lenz hj. Mol Cancer Ther. 2015 Oct;14(10):2401-8. doi: 10.1158/1535-7163.MCT-15-0359. Epub 2015 Jul 30. Mol Cancer Ther. 2015. PMID: 26227487 Free PMC article.

2

The -9Ala/-9Val polymorphism in the mitochondrial targeting sequence of the manganese superoxide dismutase gene (MnSOD) is associated with age among Hispanics with colorectal carcinoma.

Stoehlmacher J, Ingles SA, Park DJ, Zhang W, Lenz HJ. Stoehlmacher J, et al. Among authors: lenz hj. Oncol Rep. 2002 Mar-Apr;9(2):235-8. Oncol Rep. 2002. PMID: 11836586

3

Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer.

Park DJ, Stoehlmacher J, Zhang W, Tsao-Wei D, Groshen S, Lenz HJ. Park DJ, et al. Among authors: lenz hj. Int J Colorectal Dis. 2002 Jan;17(1):46-9. doi: 10.1007/s003840100358. Int J Colorectal Dis. 2002. PMID: 12018454

4

Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer.

Stoehlmacher J, Park DJ, Zhang W, Groshen S, Tsao-Wei DD, Yu MC, Lenz HJ. Stoehlmacher J, et al. Among authors: lenz hj. J Natl Cancer Inst. 2002 Jun 19;94(12):936-42. doi: 10.1093/jnci/94.12.936. J Natl Cancer Inst. 2002. PMID: 12072547

5

Targeted therapy and pharmacogenomic programs.

Iqbal S, Lenz HJ. Iqbal S, et al. Among authors: lenz hj. Cancer. 2003 Apr 15;97(8 Suppl):2076-82. doi: 10.1002/cncr.11287. Cancer. 2003. PMID: 12673699 Free article. Review.

6

Molecular predictors of treatment and outcome in colorectal cancer.

Iqbal S, Lenz HJ. Iqbal S, et al. Among authors: lenz hj. Curr Gastroenterol Rep. 2003 Oct;5(5):399-405. doi: 10.1007/s11894-003-0053-3. Curr Gastroenterol Rep. 2003. PMID: 12959721 Review.

7

Pharmacogenetic aspects in treatment of colorectal cancer--an update.

Stoehlmacher J, Goekkurt E, Lenz HJ. Stoehlmacher J, et al. Among authors: lenz hj. Pharmacogenomics. 2003 Nov;4(6):767-77. doi: 10.1517/phgs.4.6.767.22825. Pharmacogenomics. 2003. PMID: 14596640 Review.

8

Tailored chemotherapy for colorectal cancer: a new approach to therapy.

Iqbal S, Stoehlmacher J, Lenz HJ. Iqbal S, et al. Among authors: lenz hj. Cancer Invest. 2004;22(5):762-73. doi: 10.1081/cnv-200032774. Cancer Invest. 2004. PMID: 15581057 Review.

9

Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.

Zhang W, Park DJ, Lu B, Yang DY, Gordon M, Groshen S, Yun J, Press OA, Vallböhmer D, Rhodes K, Lenz HJ. Zhang W, et al. Among authors: lenz hj. Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):600-5. Clin Cancer Res. 2005. PMID: 15701846

10

Molecular determinants of cetuximab efficacy.

Vallböhmer D, Zhang W, Gordon M, Yang DY, Yun J, Press OA, Rhodes KE, Sherrod AE, Iqbal S, Danenberg KD, Groshen S, Lenz HJ. Vallböhmer D, et al. Among authors: lenz hj. J Clin Oncol. 2005 May 20;23(15):3536-44. doi: 10.1200/JCO.2005.09.100. J Clin Oncol. 2005. PMID: 15908664

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

684 results

Search Page